IP Library › Granted Patent US 12,253,513
Granted Patent B2
US 12,253,513 · App. 17/057,088 · Granted Mar 18, 2025

Methods and compositions for the selective lysis of blood cells and separation of microbial cells

Inventors: Samad Talebpour (Richmond Hill, CA); Aye Aye Khine (Thornhill, CA); Vilcy Parmar (North York, CA); Sukhdev Manku (Toronto, CA); Alaleh Samiei (Richmond Hill, CA)
Assignee: QVELLA CORPORATION
G01N33/491G01N35/00G01N2035/00495
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,253,513
App. No.
17/057,088
Granted
Mar 18, 2025
Kind
B2
Abstract

Methods and compositions are provided for the selective lysis of eukaryotic cells and the separation of microbial cells. Blood cells and/or other eukaryotic cells in a sample, may be selectively lysed by adding, to the sample, a blood lysis reagent including saponin and an alkaline buffer, and optionally sodium polyanethole sulfonate and a non-ionic surfactant, thereby forming a mixture, and agitating the mixture. Microbial cells in the mixture may then be separated, for example, using a separation method such as centrifugation or filtration, and optionally detected or cultured in growth media. Blood lysis reagent compositions are provided that are suitable for preserving the intactness of microbial cells upon mixing with the sample. In example embodiments in which the sample is a blood sample, the blood lysis reagent composition may be selected to avoid or reduce the presence of visible blood debris upon centrifugation or filtration.

Claims (43)

1. A method of separating microbial cells from a sample, the method comprising:

mixing a blood sample and a blood lysis reagent, the blood lysis reagent comprising saponin, sodium polyanethole sulfonate and an alkaline buffer, to obtain a mixture having a concentration of saponin between 0.75 and 60 mg/ml, a concentration of sodium polyanethole sulfonate between 0.35 and 50 mg/ml and a pH between 7.8 and 10; and

separating microbial cells from the mixture.

2. The method according to claim 1 wherein the blood lysis reagent has a pH in the range of 9.0-11.

3. The method according to claim 1 wherein the blood lysis reagent has a pH in the range of 9.5-10.5.

4. The method according to claim 1 wherein the blood lysis reagent is configured such that the pH of the mixture is in the range of 8.0-10.0.

5. The method according to claim 1 wherein the blood lysis reagent is configured such that the pH of the mixture is in the range of 8.5-9.5.

6. The method according to claim 1 wherein the blood lysis reagent is configured such that the pH of the mixture is in the range of 9.0-9.5.

7. The method according to claim 1 wherein the blood lysis reagent is configured such that the pH of the mixture is in the range of 8.8-9.8.

8. The method according to claim 1 wherein the blood lysis reagent is configured such that an effective buffer concentration of the mixture is in the range of 2.5-500 mM.

9. The method according to claim 1 wherein the blood lysis reagent is configured such that an effective buffer concentration of the mixture is in the range of 5-250 mM.

10. The method according to claim 1 wherein the blood lysis reagent is configured such that a concentration of saponin in the mixture is in the range of 3-60 mg/ml.

11. The method according to claim 1 wherein the blood lysis reagent is configured such that a concentration of saponin in the mixture is in the range of 10-30 mg/ml.

12. The method according to claim 1 wherein the blood lysis reagent is configured such that a concentration of sodium polyanethole sulfonate in the mixture is in the range of 3-60 mg/ml.

13. The method according to claim 1 wherein the blood lysis reagent is configured such that a concentration of sodium polyanethole sulfonate in the mixture is in the range of 1.5-50 mg/ml.

14. The method according to claim 1 wherein the blood lysis reagent is configured such that a concentration of sodium polyanethole sulfonate in the mixture is in the range of 5-20 mg/ml.

15. The method according to claim 1 wherein at least two reagents are separately stored, such that the saponin is stored separately from a basic component of the alkaline buffer.

16. The method according to claim 15 wherein the saponin is stored in an aqueous medium having a pH between 3.5 and 8.

17. The method according to claim 15 wherein the saponin is stored in an aqueous medium having a pH between 4 and 5.

18. The method according to claim 15 wherein the basic component of the alkaline buffer is stored in dry form.

19. The method according to claim 18 wherein the saponin is stored in a solution.

20. The method according to claim 1 wherein the blood lysis reagent further comprises a non-ionic surfactant.

21. The method according to claim 20 wherein the blood lysis reagent is configured such that a concentration of non-ionic surfactant in the mixture is in the range of 0-3% w/v.

22. The method according to claim 20 wherein the blood lysis reagent is configured such that a concentration of non-ionic surfactant in the mixture is in the range of 0.5-2.0% w/v.

23. The method according to claim 1 wherein the blood lysis reagent further comprises an antifoaming agent.

24. The method according to claim 23 wherein the antifoaming agent comprises an emulsion comprising polydimethylsiloxane and a non-ionic surfactant as an oil-in-water emulsifier.

25. The method according to claim 24 wherein the antifoaming agent is provided such that a concentration thereof in the mixture is in the range of 0.005-1% w/v.

26. The method according to claim 24 wherein the antifoaming agent is provided such that a concentration thereof in the mixture is in the range of 0.01-0.05% w/v.

27. The method according to claim 1 wherein the blood sample is a whole blood sample.

28. The method according to claim 27 wherein the whole blood sample has a volume exceeding 1 ml.

29. The method according to claim 27 wherein the whole blood sample has a volume exceeding 5 ml.

30. The method according to claim 1 wherein the sample is a blood culture sample.

31. The method according to claim 30 wherein the blood culture sample is a mid-culture blood culture sample obtained prior to a determination of positivity for the presence of microbial cells by an automated blood culture system.

32. The method according to claim 1 wherein the microbial cells are separated via centrifugation.

33. The method according to claim 1 wherein the microbial cells are separated via a separation method selected from the group consisting of filtration, immunomagnetic separation and microfluidic separation.

34. The method according to claim 1 further comprising:

performing an identification assay to identify the type of at least one microbial cell of the separated microbial cells.

35. The method according to claim 34 wherein the identification assay is a MALDI assay.

36. The method according to claim 1 further comprising incubating the separated microbial cells in the presence of growth media.

37. A method of separating microbial cells from a sample, the method comprising:

mixing a sample and a blood lysis reagent, the blood lysis reagent comprising saponin and an alkaline buffer, to obtain a mixture having a pH between 7.8 and 10 and a concentration of saponin suitable for effecting lysis of blood cells within the sample; and

separating microbial cells from the mixture.

38. The method according to claim 37 wherein the blood lysis reagent further comprises sodium polyanethole sulfonate.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Jul 30, 2025
From: QVELLA CORPORATION
To: SHEMRON HOLDINGS INC.
Reel/Frame 071877/0198 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 19, 2020
From: TALEBPOUR, SAMAD; KHINE, AYE AYE; PARMAR, VILCY; MANKU, SUKHDEV; SAMIEI, ALALEH
To: QVELLA CORPORATION
Reel/Frame 054424/0926 →
Continuity (3)
Provisional Application 62776126 · Dec 6, 2018
Provisional Application 62676771 · May 25, 2018
Related Publication 20210208128A1 · Jul 8, 2021
References Cited (77)
US 3883425A · Dorn · 1975 [cited by applicant]
US 4131512A · Dorn · 1978 [cited by applicant]
US 4164449A · Dorn et al. · 1979 [cited by applicant]
US 4212948A · Dorn · 1980 [cited by applicant]
US 4693972A · Mansour et al. · 1987 [cited by applicant]
US 5070014A · Dorn · 1991 [cited by applicant]
US 5108927A · Dorn · 1992 [cited by applicant]
US 5501960A · Dorn · 1996 [cited by applicant]
US 5840515A · Provost · 1998 [cited by applicant]
US 6114130A · Veriac et al. · 2000 [cited by applicant]
US 6803208B2 · Seaver et al. · 2004 [cited by applicant]
US 6864100B1 · Ribbe et al. · 2005 [cited by applicant]
US 7247484B2 · Wu et al. · 2007 [cited by applicant]
US 7939249B2 · Parthasarathy et al. · 2011 [cited by applicant]
US 8507237B2 · Hermet et al. · 2013 [cited by applicant]
US 8603769B2 · Feng et al. · 2013 [cited by applicant]
US 8741136B2 · Peters et al. · 2014 [cited by applicant]
US 8975060B2 · Talebpour et al. · 2015 [cited by applicant]
US 9574219B2 · Ronsick et al. · 2017 [cited by applicant]
US 10308976B2 · Van Meerbergen et al. · 2019 [cited by applicant]
US 20040142318A1 · Wu · 2004 [cited by examiner]
US 20060102478A1 · Robert et al. · 2006 [cited by applicant]
US 20080234474A1 · Braman et al. · 2008 [cited by applicant]
US 20110061474A1 · Page et al. · 2011 [cited by applicant]
US 20110294128A1 · Peytavi et al. · 2011 [cited by applicant]
US 20120115705A1 · Sharon et al. · 2012 [cited by applicant]
US 20120190040A1 · Talebpour et al. · 2012 [cited by applicant]
US 20120231446A1 · Heckel et al. · 2012 [cited by applicant]
US 20130171615A1 · Van Meerbergen et al. · 2013 [cited by applicant]
US 20140004501A1 · Talebpour et al. · 2014 [cited by applicant]
US 20140051113A1 · Stephenson, Jr. · 2014 [cited by examiner]
US 20140370508A1 · Grobler et al. · 2014 [cited by applicant]
US 20150125895A1 · Kircher et al. · 2015 [cited by applicant]
US 20170275612A1 · Talebpour et al. · 2017 [cited by applicant]
US 20170356018A1 · Sun · 2017 [cited by examiner]
CA 2892813 · 2014 [cited by applicant]
EP 0187266A1 · 1986 [cited by applicant]
EP 0499364A1 · 1992 [cited by applicant]
EP 0745849 · 1996 [cited by applicant]
JP 61136406A · 1986 [cited by applicant]
JP 538403A · 1993 [cited by applicant]
JP 2002193825A · 2002 [cited by applicant]
JP 2006145537A · 2006 [cited by applicant]
JP 200745788A · 2007 [cited by applicant]
JP 2016500008A · 2016 [cited by applicant]
JP 2017527301A · 2017 [cited by applicant]
WO 2008122002 · 2008 [cited by applicant]
WO 2010062354 · 2010 [cited by applicant]
WO WO2014082160A1 · 2014 [cited by examiner]
WO 2014193481 · 2014 [cited by applicant]
WO 2016044621A1 · 2016 [cited by applicant]
Bodansky, “The effect of Hydrogen Ion Concentration on Saponin Hemolysis” Journal of Biological Chemistry. vol. 82, Issue 3, Jun. 1929, pp. 567-577 (Year: 1929). [cited by examiner]
Sergey Zelenin et al., “Bacteria Isolation From Whole Blood for Sepsis Diagnostics”, 15th International Conference, Oct. 2011, 518-520. [cited by applicant]
Jinwag Tan et al., “Kinetically limited dififferential centrifugation as an inexpensive and readily available alternative to centrifugal elutriation”, BioTechniques, vol. 53, No. 2, Aug. 2012, pp. 104-108. [cited by applicant]
“Accessing Microbial Safety of Drinking Water”, World Health Organization, pp. 1-192. [cited by applicant]
S. Wilfred Ruban et al., “Physical Methods of Separation and Concentration of Microbes in Food: an Aid for Rapid Detection”, Journal of Food Technology 9(3): 106-111, 2011. [cited by applicant]
Biochemistry and Molecular Biology, Chapter 3, “Centrifugation”, pp. 1-60. [cited by applicant]
As Friberg et al., “Human islet separation utilizing a closed automated purification system”, Cell Transplant, 2008; 17(12):1305-13. [cited by applicant]
John R. Gordan, PHD, “Immunology Methods Manual, Selected Protocol”, jrg426, pp. 1-3. [cited by applicant]
Jan Koolman et al., “Color Atlas of Biochemistry”, Koolman, 2nd edition, 2005, pp. 1-476. [cited by applicant]
Lin Lin et al., “Use of the Sucrose Gradient Method for Bacterial Cell Cycle Synchronization”, Journal of Microbiology, 2014, pp. 1-4. [cited by applicant]
David Ammons et al., “An apparatus to control and automate the formation of continuous density gradients”, Analytical Biochemistry 427 (2012) 124-126. [cited by applicant]
Gilbert, “Centrifugation injury of Gram-negative bacteria, Dept of Clinical Microbiology”, Sweden, pp. 1-2. [cited by applicant]
Mathias Bernhardt et al., “Detection of Bacteria in Blood by Centrifugation and Filtration”, Journal of Clinical Microbiology, Mar. 1991, pp. 422-425. [cited by applicant]
R. Blaine McCleskey, “Electrical Conductivity of Electrolytes Found in Natural Waters From (5 to 90)”, J. Chem. Eng. Data 2011, 56, 317-327. [cited by applicant]
B. Arkles et al., “Silanes Surfaces and Interfaces, Surfaces and Interfaces Symposium”, Colorodo, Jun. 19-21, 1985, pp. 1-17. [cited by applicant]
R. Phillip Dellinger et al., “Surviving Sepsis Campaign: International guidelines for management of sever sepsis and septic shock: 2008”, Intensive Care Med (2008) 34:17-60. [cited by applicant]
Verne Schumaker et al., “Theory of Differential Centrifugation in Angle-Head Rotors”, Analytical Biochemistry 31, 279-285, 1969. [cited by applicant]
David N. Fredricks et al., “Improved Amplification of Microbial DNA from Blood Cultures by Removal of the PCR Inhibitor Sodium Polyanetholesulfonate”, Journal of Clinical Microbiology, Oct. 1998, p. 2810-2816. [cited by applicant]
Walfeed Abu AL-Soud et al., “Purification and Characterization fo PCR-Inhibitory Components in Blood Cells”, Journal of Clincial Microbiology, Feb. 2001, p. 485-493. [cited by applicant]
International Search Report in PCT/CA2019/050716 dated Aug. 16, 2019. [cited by applicant]
International Search Report in PCT/CA2013/000992 dated Mar. 28, 2014. [cited by applicant]
G.L. Dorn et al., “Copyright (1978 American Society for Microbiology New Centrifugation Blood Culture Device”. Journal of clinical Microbiology, Jan. 1, 1978, pp. 52-54. [cited by applicant]
Herbert Wiesinger-Mayr et al.: “Establishment of a semi-automated pathogen DNA isolation from whole blood and comparison with commercially available kits”, Journal of Microbiological Methods, Elsevier, Amsterdam, NL vol… [cited by applicant]
Yagupsky, Pablo, and Frederick S. Nolte. “Quantitative aspects of septicemia.” Clinical microbiology reviews 3.3 (1990): 269. [cited by applicant]
Mendonca, Aubrey F., Terry L. Amoroso, and Stephen J. Knabel. “Destruction of gram-negative food-borne pathogens by high pH involves disruption of the cytoplasmic membrane.” Applied and environmental microbiology 60.11 … [cited by applicant]
Zierdt, Charles H. “Blood-lysing solution nontoxic to pathogenic bacteria.” Journal of clinical microbiology 15.1 (1982): 172. [cited by applicant]